US NIH Fund New Cat Experiments Despite Pledge to Phase Out, Watchdog Reports
The US National Institutes of Health (NIH) has continued to fund new laboratory experiments on cats, despite stating that it is working to phase out such projects. In July this year, the NIH's acting deputy director, Dr Nicole Kleinstreuer, announced in a podcast that she did not think the NIH should do research on dogs or cats, calling it "unconscionable." However, documents uncovered by White Coat Waste (WCW), a watchdog campaigning to end taxpayer-funded animal experiments, reveal that since the July podcast, the NIH has awarded over $1.7 million in new and extended grants for experiments using cats.
The new grants include funding for studies on blood flow in the brain after stroke, gene therapy for human glaucoma, and limb coordination after injury. In each of these studies, cats are subjected to painful and distressing procedures, including having portions of their skulls removed, being injected with viruses, and undergoing strokes induced by paralysis.
WCW claims that the allocation of new funds contradicts the NIH's claim that it opposes the use of cats in experiments and argues that the NIH is misusing its policy to continue funding these projects. The watchdog also suggests that the NIH is not being transparent about its research activities and is misleading the public about its commitment to ending animal testing.
The NIH has extended seven cat studies since July with grants totaling almost $572,000, bringing the total lifetime funding for these experiments to over $38 million. Despite this, the NIH claims that it is conducting a comprehensive review of its dog and cat research portfolio to identify areas where it can responsibly transition away from animal models.
However, WCW is calling on the NIH to cancel all existing grants for cat testing and prohibit new ones. The watchdog's senior vice-president, Justin Goodman, has expressed frustration with the NIH's actions, saying that the agency has been "doubling down" on animal testing despite the availability of better alternatives.
The issue highlights the ongoing debate about the use of animals in biomedical research and the need for alternative methods to reduce the number of animals used in scientific studies. As the federal government continues to prioritize human-based research and reduce reliance on animal models, the NIH's actions are being closely scrutinized by animal welfare advocates and lawmakers.
The US National Institutes of Health (NIH) has continued to fund new laboratory experiments on cats, despite stating that it is working to phase out such projects. In July this year, the NIH's acting deputy director, Dr Nicole Kleinstreuer, announced in a podcast that she did not think the NIH should do research on dogs or cats, calling it "unconscionable." However, documents uncovered by White Coat Waste (WCW), a watchdog campaigning to end taxpayer-funded animal experiments, reveal that since the July podcast, the NIH has awarded over $1.7 million in new and extended grants for experiments using cats.
The new grants include funding for studies on blood flow in the brain after stroke, gene therapy for human glaucoma, and limb coordination after injury. In each of these studies, cats are subjected to painful and distressing procedures, including having portions of their skulls removed, being injected with viruses, and undergoing strokes induced by paralysis.
WCW claims that the allocation of new funds contradicts the NIH's claim that it opposes the use of cats in experiments and argues that the NIH is misusing its policy to continue funding these projects. The watchdog also suggests that the NIH is not being transparent about its research activities and is misleading the public about its commitment to ending animal testing.
The NIH has extended seven cat studies since July with grants totaling almost $572,000, bringing the total lifetime funding for these experiments to over $38 million. Despite this, the NIH claims that it is conducting a comprehensive review of its dog and cat research portfolio to identify areas where it can responsibly transition away from animal models.
However, WCW is calling on the NIH to cancel all existing grants for cat testing and prohibit new ones. The watchdog's senior vice-president, Justin Goodman, has expressed frustration with the NIH's actions, saying that the agency has been "doubling down" on animal testing despite the availability of better alternatives.
The issue highlights the ongoing debate about the use of animals in biomedical research and the need for alternative methods to reduce the number of animals used in scientific studies. As the federal government continues to prioritize human-based research and reduce reliance on animal models, the NIH's actions are being closely scrutinized by animal welfare advocates and lawmakers.